SCHEMBL7934134

SCHEMBL7934134

O=S(=O)(c1ccccc1)n1cc(-c2cn[nH]c2)c2cc(-c3ccccc3)nnc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 6/20 0.43
AKT1 P31749 1/20 0.40
AKT2 P31751 1/20 0.40
CA12 O43570 2/20 0.38
CA9 Q16790 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
CHEK1 O14757 2/20 0.37
PIM1 P11309 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CHUK O15111 2/20 0.36
DRD2 P14416 2/20 0.35
HTR2A P28223 2/20 0.35
HTR7 P34969 2/20 0.35
HTR1A P08908 1/20 0.35
ELAVL1 Q15717 1/20 0.35
CCNE1 P24864 1/20 0.35
CDK2 P24941 1/20 0.35
CHEK2 O96017 1/20 0.34
BRD4 O60885 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2752527 0.80 HTR6 (0.41) HTR6AKT1AKT2CA12CA9
SCHEMBL8443781 0.80 BRD4 (0.44) HTR6CA12CA9L3MBTL1CA1
SCHEMBL2280274 0.80 BRD4 (0.45) HTR6CA12CA9L3MBTL1PIM1
SCHEMBL3348977 0.79 HTR6 (0.48) HTR6DRD2HTR2AHTR7ELAVL1
SCHEMBL3348822 0.78 HTR6 (0.40) HTR6CA12CA9L3MBTL1CA1
SCHEMBL8443783 0.78 BCL2L1 (0.41) HTR6CA12CA9CA1CA2
SCHEMBL13745605 0.77 PTPN11 (0.45) HTR6CA12CA9CA1CA2
SCHEMBL2274807 0.77 BRD4 (0.50) HTR6CA12CA9L3MBTL1CA1
SCHEMBL8480893 0.76 BRD4 (0.38) HTR6CA12CA9CHUKDRD2
SCHEMBL8469870 0.76 BRD4 (0.38) HTR6CA12CA9L3MBTL1CHUK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010015803-A1 DIAZAINDOLE DERIVATIVES AND THEIR USE IN THE INHIBITION OF C-JUN N-TERMINAL KINASE EISAI R & D MANAGEMENT CO. LTD (JP) 2010-02-11 WO disclosed